Efficacy, Tolerability, and Bone Density Outcomes of Elagolix with Add-Back Therapy for Endometriosis-Associated Pain: 12 Months of an Ongoing Randomized Phase 3 Trial
American Journal of Obstetrics and Gynecology（2024）
Key words
bone density,dysmenorrhea,dyspareunia,efficacy,elagolix,endometriosis,estradiol,pain,pelvic pain,tolerability
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined